Clinical Trial Update: Study of Pemetrexed Plus Cisplatin in Advanced Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion and posting of results for a Phase 1/Phase 2 study of pemetrexed plus cisplatin in advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Neoplasm, Gastric | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2009-09-28